Literature DB >> 27455963

Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.

Mohammad Ehsanul Karim, Paul Gustafson, John Petkau, Helen Tremlett.   

Abstract

In time-to-event analyses of observational studies of drug effectiveness, incorrect handling of the period between cohort entry and first treatment exposure during follow-up may result in immortal time bias. This bias can be eliminated by acknowledging a change in treatment exposure status with time-dependent analyses, such as fitting a time-dependent Cox model. The prescription time-distribution matching (PTDM) method has been proposed as a simpler approach for controlling immortal time bias. Using simulation studies and theoretical quantification of bias, we compared the performance of the PTDM approach with that of the time-dependent Cox model in the presence of immortal time. Both assessments revealed that the PTDM approach did not adequately address immortal time bias. Based on our simulation results, another recently proposed observational data analysis technique, the sequential Cox approach, was found to be more useful than the PTDM approach (Cox: bias = -0.002, mean squared error = 0.025; PTDM: bias = -1.411, mean squared error = 2.011). We applied these approaches to investigate the association of β-interferon treatment with delaying disability progression in a multiple sclerosis cohort in British Columbia, Canada (Long-Term Benefits and Adverse Effects of Beta-Interferon for Multiple Sclerosis (BeAMS) Study, 1995-2008).
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bias (epidemiology); confounding factors (epidemiology); epidemiologic methods; immortal time bias; longitudinal studies; models; survival analysis

Mesh:

Substances:

Year:  2016        PMID: 27455963      PMCID: PMC4983651          DOI: 10.1093/aje/kwv445

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  53 in total

1.  Comparison of algorithms to generate event times conditional on time-dependent covariates.

Authors:  Marie-Pierre Sylvestre; Michal Abrahamowicz
Journal:  Stat Med       Date:  2008-06-30       Impact factor: 2.373

2.  Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.

Authors:  A Shirani; Y Zhao; M E Karim; J Petkau; P Gustafson; C Evans; E Kingwell; M L van der Kop; J Oger; H Tremlett
Journal:  Eur J Neurol       Date:  2013-12-18       Impact factor: 6.089

3.  Survivor treatment bias, treatment selection bias, and propensity scores in observational research.

Authors:  Peter C Austin; Robert W Platt
Journal:  J Clin Epidemiol       Date:  2010-02       Impact factor: 6.437

4.  On the relationship between response to treatment and survival time.

Authors:  M Buyse; P Piedbois
Journal:  Stat Med       Date:  1996-12-30       Impact factor: 2.373

5.  Further results on the non-parametric linear regression model in survival analysis.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1993-09-15       Impact factor: 2.373

6.  Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome.

Authors:  P Michael Ho; Stephan D Fihn; Li Wang; Chris L Bryson; Elliott Lowy; Charles Maynard; David J Magid; Eric D Peterson; Robert L Jesse; John S Rumsfeld
Journal:  Am Heart J       Date:  2007-10-24       Impact factor: 4.749

7.  The relationship of blood product ratio to mortality: survival benefit or survival bias?

Authors:  Christopher W Snyder; Jordan A Weinberg; Gerald McGwin; Sherry M Melton; Richard L George; Donald A Reiff; James M Cross; Jennifer Hubbard-Brown; Loring W Rue; Jeffrey D Kerby
Journal:  J Trauma       Date:  2009-02

8.  Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.

Authors:  Afsaneh Shirani; Yinshan Zhao; Mohammad Ehsanul Karim; Charity Evans; Elaine Kingwell; Mia L van der Kop; Joel Oger; Paul Gustafson; John Petkau; Helen Tremlett
Journal:  JAMA       Date:  2012-07-18       Impact factor: 56.272

9.  Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures.

Authors:  S Morin; E Rahme; H Behlouli; A Tenenhouse; D Goltzman; L Pilote
Journal:  Osteoporos Int       Date:  2007-07-19       Impact factor: 4.507

10.  Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.

Authors:  Afsaneh Shirani; Yinshan Zhao; John Petkau; Paul Gustafson; Mohammad Ehsanul Karim; Charity Evans; Elaine Kingwell; Mia L van der Kop; Joel Oger; Helen Tremlett
Journal:  Biomed Res Int       Date:  2015-04-01       Impact factor: 3.411

View more
  18 in total

1.  Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.

Authors:  Mohammad Ehsanul Karim; John Petkau; Paul Gustafson; Robert W Platt; Helen Tremlett
Journal:  Stat Methods Med Res       Date:  2016-09-21       Impact factor: 3.021

2.  Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV.

Authors:  Chukwuemeka N Okafor; Michael W Plankey; David Goodman-Meza; Michael Li; Karla J Bautista; Hector Bolivar; Tien C Phyllis; Todd T Brown; Steven J Shoptaw
Journal:  Drug Alcohol Depend       Date:  2020-02-20       Impact factor: 4.492

3.  Cancer as a risk factor for urinary tract calculi: a retrospective cohort study using 'The Health Improvement Network' : Cancer and urinary tract calculi.

Authors:  Ankush Mittal; Motaz Elmahdy Hassan; Joht Singh Chandan; Brian H Willis; Krishnarajah Nirantharakumar; Kesvapilla Subramonian
Journal:  Urolithiasis       Date:  2019-03-16       Impact factor: 3.436

4.  Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Authors:  Janick Weberpals; Lina Jansen; Myrthe P P van Herk-Sukel; Josephina G Kuiper; Mieke J Aarts; Pauline A J Vissers; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

5.  Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure.

Authors:  Michelle Samuel; Michal Abrahamowicz; Jacqueline Joza; Marie-Eve Beauchamp; Vidal Essebag; Louise Pilote
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

6.  Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.

Authors:  Balachandran Kumarendran; Michael W O'Reilly; Konstantinos N Manolopoulos; Konstantinos A Toulis; Krishna M Gokhale; Alice J Sitch; Chandrika N Wijeyaratne; Arri Coomarasamy; Wiebke Arlt; Krishnarajah Nirantharakumar
Journal:  PLoS Med       Date:  2018-03-28       Impact factor: 11.069

7.  Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers.

Authors:  Jacinthe Leclerc; Claudia Blais; Louis Rochette; Denis Hamel; Line Guénette; Claudia Beaudoin; Paul Poirier
Journal:  Drugs R D       Date:  2020-06

8.  Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database.

Authors:  Parul Agarwal; Erin Moshier; Meng Ru; Nisha Ohri; Ronald Ennis; Kenneth Rosenzweig; Madhu Mazumdar
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

9.  Mortality in homeless people enrolled in the French housing first randomized controlled trial: a secondary outcome analysis of predictors and causes of death.

Authors:  Aurélie Tinland; Sandrine Loubiere; Matthieu Cantiello; Mohamed Boucekine; Vincent Girard; Owen Taylor; Pascal Auquier
Journal:  BMC Public Health       Date:  2021-07-02       Impact factor: 3.295

10.  Statin for Tuberculosis and Pneumonia in Patients with Asthma⁻Chronic Pulmonary Disease Overlap Syndrome: A Time-Dependent Population-Based Cohort Study.

Authors:  Jun-Jun Yeh; Cheng-Li Lin; Chung-Y Hsu; Zonyin Shae; Chia-Hung Kao
Journal:  J Clin Med       Date:  2018-10-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.